The Preoperative Risks and Two-Year Sequelae of Postoperative Urinary Retention: Analysis of the Michigan Spine Surgery Improvement Collaborative (MSSIC).


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 09 04 2019
revised: 19 09 2019
accepted: 20 09 2019
pubmed: 1 10 2019
medline: 25 1 2020
entrez: 1 10 2019
Statut: ppublish

Résumé

Although postoperative urinary retention (POUR) is common after spine surgery, the association of this adverse event with other morbidities and patient-reported outcomes is not fully understood. We sought to examine the sequelae of POUR after lumbar spine surgery. The Michigan Spine Surgery Improvement Collaborative (MSSIC) is a large prospective multicenter registry. MSSIC was queried with multivariate analysis for factors that are associated with POUR, the association of POUR with 90-day adverse events, and the effect of POUR on 2-year patient-reported outcomes and satisfaction. Multivariate analysis identified hardware revision (odds ratio [OR], 0.61), 1 operative level (OR, 0.74), and ambulation on postoperative day zero (OR, 0.65) to be protective for POUR. Factors associated with POUR included age (OR, 1.19), male gender (OR, 1.58), body mass index <25 (OR, 1.22), diabetes (OR, 1.28), coronary artery disease (OR, 1.20), fusion surgery (OR, 1.27), and longer surgery (OR, 1.11). Patients who had POUR were more likely to be readmitted, develop a urinary tract infection, and develop an infection (P < 0.001). POUR was associated with decreased likelihood of achieving Oswestry Disability Index minimal clinically important difference at 90 days (P < 0.001), but not at 1 year after surgery. POUR was associated with dissatisfaction with surgery at 90 days (P < 0.001), 1 year (P = 0.004), and 2 years after surgery (P = 0.011). POUR is common after lumbar spine surgery, and the demographic, diagnostic, and surgical factors that are associated with POUR are identified. POUR is associated with several adverse events, and patients who have POUR were less likely to be satisfied with surgery up to 2 years after surgery.

Identifiants

pubmed: 31568914
pii: S1878-8750(19)32538-0
doi: 10.1016/j.wneu.2019.09.107
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e619-e626

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Hesham Mostafa Zakaria (HM)

Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan, USA.

Matthew Lipphardt (M)

Department of Orthopaedic Surgery, Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA; Division of Orthopaedic Surgery, Beaumont Health Troy, Troy, Michigan, USA.

Michael Bazydlo (M)

Department of Public Health Research, Henry Ford Hospital, Detroit, Michigan, USA.

Shujie Xiao (S)

Department of Public Health Research, Henry Ford Hospital, Detroit, Michigan, USA.

Lonni Schultz (L)

Department of Public Health Research, Henry Ford Hospital, Detroit, Michigan, USA.

Mokbel Chedid (M)

Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan, USA.

Muwaffak Abdulhak (M)

Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan, USA.

Jason M Schwalb (JM)

Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan, USA.

David Nerenz (D)

Center for Health Services Research, Henry Ford Hospital, Detroit, Michigan, USA.

Richard Easton (R)

Department of Orthopaedic Surgery, Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA; Division of Orthopaedic Surgery, Beaumont Health Troy, Troy, Michigan, USA.

Victor Chang (V)

Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan, USA. Electronic address: vchang1@hfhs.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH